Get started
rmcnally11

Low downside

Long
bluebird bio, Inc. (BATS:BLUE)  
rmcnally11  
BATS:BLUE   bluebird bio, Inc.
Fundamental Analysis Beyond Technical Analysis
0
0
fundamental beyondta

Asymmetric upside here on a biotech stock that's been absolutely battered. Runway for pharmaceutical approvals are ripe and Dec 20 could launch this.
RJM11.eth
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.